Background Even after successful slow pathway (SP) ablation for atrioventricular-nodal reentrant tachycardia (AVNRT), there may be clinical recurrence in certain patients and it is clinically important to be able to predict that.
adiofrequency catheter ablation is a feasible and useful therapeutic procedure for atrioventricular nodal reentrant tachycardia (AVNRT), but although electrophysiologic studies (EPS) show high success rates for the procedure, 0-14.6% of cases have clinical recurrence during the follow-up period of 1-45 months even after successful slow pathway (SP) ablation. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Several investigators have reported that some electrophysiologic parameters at the time of the first session of SP ablation (eg, residual SP, [1] [2] [3] [4] residual single echo beat 2, 4 and no junctional beats during ablation 2 ) may be useful for predicting the recurrence of AVNRT, but general consensus has not yet been established. In the present study, several electrophysiologic parameters at the time of SP ablation in cases of AVNRT, especially the changes in the conduction patterns through the atrioventricular node (AVN), were evaluated and compared with the presence of clinical AVNRT recurrence.
Methods

Patients and EPS
Between November 1995 and December 2001, 132 consecutive patients with common type AVNRT underwent SP ablation. Of these, 2 patients still showed inducible AVNRT after ablation and 1 patient had advanced AV block during the 48 h after ablation. Excluding these 3 patients, 129 patients successfully completed the SP ablation procedure and for this study, we selected 97 patients who had demonstrated inducible AVNRT and also showed dual or multiple AVN physiology in the atrial extra-stimulations. After informed consent was obtained, the EPS was performed in the fasting state without any sedative medications. Antiarrhythmic drugs were discontinued for at least 5 half-lives before the ablation. Three 5F quadripolar electrode catheters were introduced via the femoral vein, and were positioned against the high right atrium (HRA), the His bundle region, and the right ventricular apex (RVA) under fluoroscopic guidance. One 5F decapolar catheter was introduced into the coronary sinus via the jugular vein. 12 Between 1995 and 1998, patients' data were analyzed on a paper recording at 100 mm/s (Model VR-13, Biomedical Systems, USA), and between 1999 and 2001 data were stored for analysis on optical disks using a computerrecording system and were analyzed on screen (Cardio Lab System, Marquette, MI, USA).
Basic Study and Diagnosis
Single-extra-stimulation and incremental pacing were performed at the HRA and RVA sites for the basic electrophysiological evaluation. Prolongation of the atrio-His (AH) interval of not less than 50 ms in response to the shortening of the coupling interval of the premature atrial stimulus by 10 ms was defined as the 'jump-up' phenomenon of the AH interval. 13 When the single atrial stimulus could not induce the AH jump-up, a double-atrialextra-stimulus protocol was performed to achieve shorter premature coupling intervals. 14 AVNRT was diagnosed in accordance with the following criteria: (1) the jump-up phenomenon of the AH interval after single or double atrial (3) simultaneous activation of the atrium and ventricle during tachycardia. 15 The second criterion was confirmed by single-ventricle scanning during tachycardia and sinus rhythm to exclude orthodromic AV reciprocal tachycardia involving an accessory pathway. Patients were excluded from eligibility for common type AVNRT if they were considered to have slow-slow AVNRT with lower common pathway based on the finding of a retrograde atrial activation sequence during tachycardia or based on the comparison of ventricular-atrial intervals during tachycardia and ventricular pacing. When tachycardia could not be induced in the basic state, isoproterenol (ISP) was infused intravenously at a dose rate of 0.2-0.5 g/min per kg to increase the basic sinus rate by 20-25%, and the same stimulation protocol was repeated.
SP Ablation
After the basic EPS, a 7F quadripolar steerable ablation catheter with 4 mm-tip (Marinr, Medtronic, USA) was introduced through the femoral vein. The catheter tip was initially positioned along the tricuspid annulus anterior to the ostium of the coronary sinus. In the lowest one-third of the area between the recording site at the His bundle and the ostium of the coronary sinus, the optimal ablation site was determined under guidance of the Asp potential as described by Jackman et al 16 with an A/V ratio of 0.1 to 0.5. Radiofrequency energy was delivered with a temperature controlled ablation unit (Atakr RF Ablation system, Medtronic) at 60°C during sinus rhythm. If a junctional beat was recognized within 10 s, the energy delivery was continued for 1 min, and was terminated immediately in the cases showing an impedance rise or any signs of AH block. After each ablation procedure, the pacing protocol was repeated to evaluate the inducibility of AVNRT. When AVNRT was still inducible, the ablation catheter was repositioned to a more superior region along the tricuspid annulus and the ablation procedure was continued. The ablation procedure was considered to be successful when AVNRT could not be induced 10 min after the last delivery of radiofrequency energy. In the post-ablation study, ISP was infused only when it had been needed for AVNRT induction in the basic state before the ablation (n=14). Single atrial echo beat or jump-up of the AH interval was allowed to remain.
Electrophysiologic Parameters Fast Pathway (FP)-Effective Refractory Period (ERP)
The ERP of the FP of the AVN that caused the jump-up phenomenon.
SP-ERP The longest coupling interval of the atrial extrastimulus that failed to propagate to the His bundle. In patients in which atrial ERP was longer than the SP-ERP, the atrial ERP was used as a conservative estimation of the SP-ERP. 17 ∆AH The prolongation of the AH interval at the time of jump-up. It was calculated by subtracting the AH interval before the jump-up from that after the jump-up phenomenon. This parameter was practically considered to be the difference in conduction times between the fast and slow pathways. In patients with triple AVN pathways, the AH prolongation at the first jump-up was regarded as ∆AH.
∆FP-ERP The change in FP-ERP caused by successful SP ablation. It was calculated by subtracting FP-ERP at the baseline before the ablation from FP-ERP after the ablation (Fig 1) .
∆SP-ERP The change in the SP-ERP of the patients with residual SP after successful SP ablation. It was calculated by subtracting SP-ERP at the baseline before the ablation from SP-ERP after the ablation (Fig 1) .
∆∆AH The change in ∆AH observed after successful SP ablation. It was calculated by subtracting ∆AH at the baseline before the ablation from ∆AH after the ablation (Fig 1) .
All parameters were recorded and evaluated at a basic cycle length of 600 ms. Elimination of the slow pathway was defined as disappearance of the AVN jump-up phenomenon observed before ablation. The presence of the AVN jump-up phenomenon before and after ablation was investigated under identical protocols. Therefore, the patients undergoing double atrial premature stimulation (S1-S2-S3) before ablation were examined using the same interval of S1-S2 after ablation (n=7). All data of the postablative state were evaluated 10 min after the last delivery of radiofrequency energy.
Early Revival and Late Clinical Recurrence of AVNRT
The appearance of AVNRT after successful SP ablation was classified into 2 categories.
(1) Early revival, defined as AVNRT in response to atrial premature stimulation performed 30 min after the last radiofrequency energy delivery. Patients with early revival of AVNRT underwent a repeat ablation procedure and were excluded from the long-term follow-up protocol.
(2) Late clinical recurrence, defined as spontaneous recurrence of AVNRT during the long-term clinical followup.
Statistical Analysis
The data were expressed as the mean value ± SD. Comparisons of the electrophysiological data were performed using the analysis of variance. Two-tailed unpaired Student's ttests were used to compare the data between groups. A value of p<0.05 was considered to be statistically significant.
Results
Recurrence of AVNRT
Among the 129 cases of AVNRT with successful SP ablation, there were 6 cases of early revival and 10 of late clinical recurrence. Among the 97 patients, 4 patients showed early revival and 10 showed late clinical recurrence during the follow-up period of 59±16 months (range: 9-80 months). All episodes of late clinical recurrence were characterized by the symptom of palpitation, and were confirmed electrocardiographically. Tachycardia that recurred after ablation showed a similar cycle length (392±42 ms) to that before ablation (393±41 ms), and the QRS and P waves on the electrocardiogram were similar to those before ablation. In patients with acute revival, the slow -fast form of tachycardia after ablation showed a similar mean cycle length (425±70 ms) to the before ablation (395±33 ms). Table 1 shows the clinical and electrophysiological characteristics of the patients with no-recurrence (n=83), acute revival (n=4), and late clinical recurrence (n=10) of AVNRT. There were no differences in age, sex, the number of radiofrequency applications or average energy delivery among the 3 groups. Junctional rhythm during ablation was not observed in 10 of 97 patients, and the incidence of 'no junctional rhythm' did not differ among the 3 groups. Transient AV block was observed in only 1 patient with non-recurrence. There were no differences in either FP-ERP before and after ablation, or in ∆FP-ERP among the 3 groups. SP-ERP or ∆AH before ablation did not differ among the 3 groups. Residual SP in the post-ablative state was recognized in all of the 10 recurrent patients (100%), and in 41 of 83 non-recurrent patients (49%, p=0.002). A single echo beat in the post-ablative state was recognized in 9 of the 10 recurrent patients (90%), and in 33 of the 83 non-recurrent patients (40%, p=0.007). There was no difference in the existence of triple AVN pathways in the baseline study among the 3 groups. Table 2 shows the FP-ERP, SP-ERP, and ∆AH in patients with residual SP, revealing that there were no differences in either FP-ERP, before or after ablation, or in ∆FP-ERP among the 3 groups. Further more, no differences were observed in SP-ERP before or after ablation, or in ∆SP-ERP among the groups. Although ∆AH before ablation did not show a significant difference between the groups, ∆AH in the post-ablative state was longer (114±33 vs 91±23 ms, p=0.047), and the ∆∆AH was larger (24±30 vs 4±7 ms, p=0.042), in non-recurrent patients than in late clinical recurrent patients. Fig 2 shows the distributions of ∆FP-ERP and ∆∆AH in patients with residual SP. Patients with late clinical recurrence showed little change in the ∆∆AH compared with the non-recurrent patients. Patients with acute revival or late clinical recurrence showed a ∆∆AH of not more than 40 ms. Table 3 shows the sensitivities, specificities, positive predictive values, and negative predictive values of the electrophysiological parameters after SP ablation for predicting the acute revival or late clinical recurrence of AVNRT. Residual SP and echo beat showed relatively high sensitivities (92.9% and 85.7%, respectively), but relatively low specificities (50.6% and 60.2%, respectively). In contrast, residual SP with ∆∆AH ≤ 10 ms showed high sensitivity (85.7%) and high specificity (75.9%) for predicting acute revival or late clinical recurrence.
AVNRT Recurrence and the Electrophysiologic Parameters
Discussion
End-Point of the SP Ablation Procedure
After successful SP ablation, AVNRT is reported to recur in 0-14.6% of patients. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] In the present study, late clinical AVNRT recurrence was observed in 10 of 129 patients (7.8%), therefore being able to predict the recurrence of AVNRT after the ablation procedure is important. Some investigators have suggested that complete elimination of SP conduction is a desirable goal, 1 but there are cases of broad SP and sometimes it may be difficult to achieve this end-point. 18 We ablated the SP by targeting the Asp potential and followed the classical end-points of Jackmann et al 16 and Haissaguerre et al. 10 As a result, we achieved complete elimination of SP conduction in 44.3% of the patients. If SP ablation was continued in patients with residual SP, complete elimination of SP might have been achieved, but it is questionable whether continuous SP ablation should be carried out from the standpoint of avoiding AV block and prolonged X-ray exposure. 18, 19 
Electrophysiologic Parameters for Predicting AVNRT Recurrence
The electrophysiologic parameters that are considered to be useful for predicting AVNRT recurrence are residual SP, 1-4 residual single echo beat, 2,4 no junctional beats during ablation, 2,20 the location of the ablation site 6 and the morphology of the A wave. 3 Concerning the relationship between residual SP and AVNRT recurrence, some investigators who have used ISP after ablation have suggested that residual SP is not a risk factor for recurrence. [5] [6] [7] [8] [9] [10] [11] Others who have used ISP or atropine after ablation agree that it is a risk factor. [2] [3] [4] Therefore, general consensus on the risk factors for AVNRT recurrence has not been established. Several parameters for evaluating the characteristics of residual SP conduction after ablation have been reported: changes in SP conduction (ie, the decrease of 1:1 conduction ability 10, 16 ) or a small ERP window between the fast and slow pathways 2 may be negative predictors for AVNRT recurrence. Therefore, a specific change in the characteristics of SP conduction may be predictive for recurrence. In the present study, among the patients showing residual SP, those with late clinical recurrence showed ∆∆AH of 4±7 ms, and 24±30 ms in those without recurrence (p=0.042, Table 2 ), which indicates that the patients with a smaller changes in ∆AH after ablation, especially with ∆∆AH ≤ 10 ms, have a higher incidence of recurrence (Table 3 ). In contrast, no recurrence or acute revival was observed in patients with ∆∆AH of more than 40 ms (Fig 2) . It was not clear why there were the changes in the SP conduction properties after ablation (eg, ∆AH prolongation). However, the reasons might include modification of SP by radiofrequency energy or an additional SP was uncovered by the elimination of the targeted SP. Prolongation of the ∆AH indicates that this additional SP had a slower conduction property than the ablated SP, which might prevent it from constructing an active reentrant circuit, resulting in lower recurrence.
Clinical Implications
The rate of recurrence of AVNRT after SP ablation was lower when (1) the SP was eliminated completely or (2) the ∆AH was prolonged by more than 40 ms after ablation in patients with residual SP. The ∆∆AH is a simple and useful marker for predicting AVNRT recurrence in patients with residual SP.
Study Limitations
First, it was difficult to completely equalize the autonomic state before and after ablation procedure, especially when ISP was used. We consider that the evaluations after ablation may have been influenced by autonomic change. Second, the ∆AH could be related to changes in the FP-AH as well as those of the SP-AH. In addition, SP-AH was measured at different stimulation intervals in patients showing different FP-ERP after ablation. Although there was no significant correlation between ∆FP-ERP and ∆∆AH (r=-0.22, NS, Fig 2) , changes in FP-AH and SP-AH at the different stimulation intervals were not clear in our data. The third limitation is that we did not use ISP in the 52 of 83 non-recurrent, 3 of 4 acute revival and 4 of 10 recurrent patients after the post-ablation study. Because there were some recurrent patients who did not undergo the post-ablation ISP study, other SP conduction characteristics and the inducibility of AVNRT, including using ISP, should be especially evaluated in patients with little change in ∆AH after ablation. The fourth limitation was the ∆AH measurement in patients with triple AVN pathways. We considered measurement of parameters at the first jump-up point might not be useful in all cases of multiple AVN SP, but SP related to clinical tachycardia should be evaluated.
